Mana.bio

Mana.bio is a seed stage biotech company specializing in AI-driven drug delivery solutions for gene therapy, including mRNA-based therapeutics, vaccines, and gene editing. Their technology integrates machine learning and nanotechnology to design and optimize lipid nanoparticles (LNPs), which serve as delivery vehicles for these therapies. By leveraging AI, Mana.bio aims to overcome the limitations of traditional drug delivery methods and create programmable drug treatments that can target specific tissues and organs with increased precision and efficacy.

The company is founded and led by a team of experienced entrepreneurs and experts in drug delivery, machine learning, and software development. Their mission is to disrupt the drug delivery space and accelerate the development of groundbreaking therapies by combining advanced technologies in biology and medicine. Mana.bio has garnered significant attention and investment, securing funding from leading investors such as Andreessen Horowitz Bio + Health, Base4 Capital, and NFX.

Mana.bio's website doesn't provide specific information regarding job flexibility like remote work options or flexible hours.

Mana.bio is an AI-driven drug delivery startup focused on revolutionizing gene therapy with DNA and RNA-based therapeutics and vaccines. They aim to disrupt the drug delivery space by leveraging machine learning and nanotechnology to create precise and optimized lipid nanoparticle formulations. This innovative approach promises to accelerate drug development, unlock new therapeutic possibilities, and address unmet needs in the biotech and pharmaceutical industries.

Mana.bio fosters a collaborative and innovative culture, driven by a shared passion for leveraging technology to improve human health. The company prioritizes cross-functional teamwork, encouraging open communication and knowledge sharing between scientists, engineers, and business professionals. Mana.bio values a results-oriented approach, promoting a dynamic and fast-paced environment that embraces experimentation and data-driven decision making. The company's commitment to scientific excellence and entrepreneurial spirit is reflected in its leadership, which includes experienced repeat entrepreneurs and highly regarded experts in the field of drug delivery, machine learning, and software development.